Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jul 23, 2012
For more info, visit http://www.bio-rad.com/yt/4/ProteinIn.... An increasing number of diseases are now being associated with misfolding, aggregation, and tissue deposition of specific proteins. A well-known example is Alzheimer's disease (AD). The condition is characterized by the aggregation of β-amyloid peptides (Aβ1--40 and Aβ1--42), which form amyloid plaques. The plaques are mainly composed of insoluble Aβ fibrils formed by fibrillogenesis. However, recent evidence suggests a pathogenic role for soluble oligomers appearing early in the fibrillogenesis process.
This webinar illustrates unconventional applications of surface plasmon resonance (SPR) to measure the kinetics of the elongation of Aβ1--42 fibrils and recognize soluble Aβ1--42 oligomeric species, which cannot be achieved by other techniques. These approaches are very useful in screening mutations or potential anti-amyloidogenic drugs for their effects on fibrillogenesis and the formation of toxic oligomers.
Presenter: Marco Gobbi Head, Laboratory of Pharmacodynamics and Pharmacokinetics Istituto di Ricerche Farmacologiche Mario Negri Milano Italy